MARKET

ATRC

ATRC

AtriCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

38.25
+1.51
+4.11%
After Hours: 38.25 0 0.00% 16:30 01/17 EST
OPEN
37.01
PREV CLOSE
36.74
HIGH
38.26
LOW
36.42
VOLUME
790.59K
TURNOVER
--
52 WEEK HIGH
38.26
52 WEEK LOW
22.57
MARKET CAP
1.51B
P/E (TTM)
-60.2078
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATRC News

  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.21h ago
  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
  • Benzinga.2d ago
  • AtriCure provides Q4, FY19 outlook
  • Seeking Alpha - Article.4d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
+0.29%

Hot Stocks

Name
Price
%Change

About ATRC

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
More

Webull offers AtriCure Inc. (ATRC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.